EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT
BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:49a63bd667664ece8c48bf56eb084b0e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:49a63bd667664ece8c48bf56eb084b0e2021-11-10T09:07:36ZEFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT1561-41072251-7170https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e2008-08-01T00:00:00Zhttp://jbums.org/article-1-2465-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice and rats. The aim of this study was to investigate the neuroprotective effects of α-TCT and RGZ at 3 hours after cerebral ischemia. METHODS: In this experimental study, stroke was induced by embolizing a preformed clot into the MCA. Male Wistar rats (300-350 gr) were assigned to α-TCT (1 or 10 mg/kg), rosiglitazone (RGZ) and sham-operation. The drugs were injected i.p. Stained brain sections were scanned and infarct area were determined using a picture analyzer software. FINDINGS: Forty eight hours after embolic ischemia, infarct volume in the control, RGZ, low and high doses of α-TCT were 29.4±2.6%, 15.9±3.1%, 24.9±2.1% and 29±4.8%, respectively. There was a significant difference between control and RGZ groups (p<0.05). Compared to the control group, the low and high doses of α-TCT didn’t show any significant difference. Furthermore, only RGZ decreased neurological deficits (p<0.05) and sensory impairments (p<0.01). CONCLUSION: Administration of α-TCT at 3 hr after induction of cerebral ischemia is not neuroprotective but RGZ may have beneficial effects on treatment and management of stroke. So further studies are needed to survey the neuroprotective effects of α-TCT after stroke.MA AllahtavakoliA ShamsizadehM Mahmoodi,R Moloudi,ME RezvaniBabol University of Medical Sciencesarticlecerebral ischemiaembolic modelα-tocotrienolvitamin eneuroprotectionMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 10, Iss 3, Pp 7-14 (2008) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN FA |
topic |
cerebral ischemia embolic model α-tocotrienol vitamin e neuroprotection Medicine R Medicine (General) R5-920 |
spellingShingle |
cerebral ischemia embolic model α-tocotrienol vitamin e neuroprotection Medicine R Medicine (General) R5-920 MA Allahtavakoli A Shamsizadeh M Mahmoodi, R Moloudi, ME Rezvani EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
description |
BACKGROUND AND OBJECTIVE: Stroke is one of the leading causes of death and disability in the world. Previous studies have demonstrated that α-tocotrienol (α-TCT) and rosiglitazone (RGZ) reduce ischemic damage by middle cerebral artery (MCA) occlusion when administered before ischemic stroke in mice and rats. The aim of this study was to investigate the neuroprotective effects of α-TCT and RGZ at 3 hours after cerebral ischemia. METHODS: In this experimental study, stroke was induced by embolizing a preformed clot into the MCA. Male Wistar rats (300-350 gr) were assigned to α-TCT (1 or 10 mg/kg), rosiglitazone (RGZ) and sham-operation. The drugs were injected i.p. Stained brain sections were scanned and infarct area were determined using a picture analyzer software. FINDINGS: Forty eight hours after embolic ischemia, infarct volume in the control, RGZ, low and high doses of α-TCT were 29.4±2.6%, 15.9±3.1%, 24.9±2.1% and 29±4.8%, respectively. There was a significant difference between control and RGZ groups (p<0.05). Compared to the control group, the low and high doses of α-TCT didn’t show any significant difference. Furthermore, only RGZ decreased neurological deficits (p<0.05) and sensory impairments (p<0.01). CONCLUSION: Administration of α-TCT at 3 hr after induction of cerebral ischemia is not neuroprotective but RGZ may have beneficial effects on treatment and management of stroke. So further studies are needed to survey the neuroprotective effects of α-TCT after stroke. |
format |
article |
author |
MA Allahtavakoli A Shamsizadeh M Mahmoodi, R Moloudi, ME Rezvani |
author_facet |
MA Allahtavakoli A Shamsizadeh M Mahmoodi, R Moloudi, ME Rezvani |
author_sort |
MA Allahtavakoli |
title |
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
title_short |
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
title_full |
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
title_fullStr |
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
title_full_unstemmed |
EFFECT OF α-TOCOTRIENOL AND PROXISOME PROLIFRATIVE-ACTIVATED RECEPTOR LIGAND ON THE BRAIN ISCHEMIA IN MALE RAT |
title_sort |
effect of α-tocotrienol and proxisome prolifrative-activated receptor ligand on the brain ischemia in male rat |
publisher |
Babol University of Medical Sciences |
publishDate |
2008 |
url |
https://doaj.org/article/49a63bd667664ece8c48bf56eb084b0e |
work_keys_str_mv |
AT maallahtavakoli effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat AT ashamsizadeh effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat AT mmahmoodi effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat AT rmoloudi effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat AT merezvani effectofatocotrienolandproxisomeprolifrativeactivatedreceptorligandonthebrainischemiainmalerat |
_version_ |
1718440277787541504 |